Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Immunovant Sciences GmbH
University of Chicago
University of Pittsburgh
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Arcellx, Inc.
Center for International Blood and Marrow Transplant Research
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sir Mortimer B. Davis - Jewish General Hospital
Kyverna Therapeutics
Brain Inflammation Collaborative
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
University of Pittsburgh
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Cabaletta Bio
UNC Lineberger Comprehensive Cancer Center
Essen Biotech
Assistance Publique - Hôpitaux de Paris
RemeGen Co., Ltd.
University of California, Davis
First Affiliated Hospital of Wenzhou Medical University
University of California, San Diego
University of California, San Diego
University of California, San Diego
MiraKind
Yale University
Imperial College London
First Affiliated Hospital of Wenzhou Medical University
Tongji Hospital
Tongji Hospital
University College, London
Washington University School of Medicine
RenJi Hospital
Assistance Publique - Hôpitaux de Paris
University of Haifa
Georgetown University
Atara Biotherapeutics
Clarteis
The Second Affiliated Hospital of Chongqing Medical University
Sohag University
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
Alliance Foundation Trials, LLC.